Abstract:
A diagnostic method and kit are disclosed for detection of cancer. Detection of elevated levels of N-myristoyltransferase (NMT) or NMT activity in blood or bone marrow, and specifically in peripheral blood mononuclear cells, can be used as a marker for cancer. The use of this method for detection of adenocarcinoma, such as colorectal cancer, is exemplified.
Abstract:
The use of GapC plasmin binding proteins from Streptococcus dysgalactiae (S. dysgalactiae) , Streptococcus agalactiae (S. agalactiae) , Streptococcus uberis (S. uberis) , Streptococcus parauberis (S. parauberis) , and Streptococcus iniae (S. iniae) in combination with CAMP factors is described, to prevent or treat bacterial infections in general, and mastitis in particular.
Abstract:
The use of GapC plasmin binding proteins from Streptococcus dysgalactiae (S. dysgalactiae) , Streptococcus agalactiae (S. agalactiae) , Streptococcus uberis (S. uberis) , Streptococcus parauberis (S. parauberis) , and Streptococcus iniae (S. iniae) in combination with CAMP factors is described, to prevent or treat bacterial infections in general, and mastitis in particular.
Abstract:
In various aspects, the invention provides molecular systems for storing and retrieving information. In some embodiments, polymers capable of selectively binding metal ions, such as nucleic acids, are used to record information in the form of a particular molecular conformation. Electrochemical assay methods employing nanopores may be used to read and write information using such polymeric media. In some embodiments, information may be recorded in a nucleic acid polymer by magnetically modulating the translocation of the nucleic acid through a channel in a medium, while simultaneously modulating the electrostatic potential across the channel. In this way, the incorporation of a divalent metal ion in the nucleic acid duplex may be modulated to store information. In an alternative aspect, the invention provides analogous processes for detecting a base pair mismatch in a nucleic acid polymer.
Abstract:
The invention provides novel methods and compositions for promoting weight gain in non-human animals comprising immunostimulatory nucleic acids. The invention similarly provides methods and compositions for promoting innate immunity in young non-human animals.
Abstract:
Mammalian cells and tissues are cultured and preserved by mixing the cells or tissues with an extender derived from phosphatidyl-choline of plant origin, e.g. soybeans, and lowering the temperature of the mixture sufficiently to preserve the mammalian cells and tissues in viable form.
Abstract:
Organic circuit elements and methods are disclosed. An organic circuit element includes a plurality of members, each of which includes an oligonucleotide duplex. The plurality of members includes at least one donor member for receiving conduction electrons from an electron donor, at least one acceptor member for communicating with an electron acceptor to provide a region of attraction for the conduction electrons, and at least one regulator member intersecting with at least one of the plurality of members to define at least one electric field regulation junction, for cooperating with an electric field regulator to regulate an electric field at the junction. A method of regulating an electronic signal between first and second locations in a conductive nucleic acid material includes varying an electrostatic potential at a third location in the nucleic acid material interposed between the first and second locations. The third location may include the regulation junction.
Abstract:
Compositions and methods for stimulating an immune response against a secreted enterohemorragic Escherichia coli (EHEC) antigen are disclosed. The compositions comprise EHEC cell culture supernatants.
Abstract:
New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected GnRH multimer which consists essentially of at least one repeating GnRH decapepetide sequence, or at least one repeating unit of a sequence corresponding to at least one epitope of a selected GnRH molecule. Under the invention, the selected GnRH sequences may all be the same, or may correspond to different derivatives, analogues, variants or epitopes of GnRH so long as the GnRH sequences are capable of eliciting an immune response. The leukotoxin functions to increase the immunogenicity of the GnRH multimer fused thereto.